Advertisement
Kip 25

Parnassus Mid Cap Fund Suffers a Toothache

This Kiplinger 25 member is in a slump.

A member of the Kiplinger 25, our favorite no-load mutual funds, Parnassus Mid Cap (PARMX), which invests in growing midsize firms and boasts a 10-year record that beats 94% of mid-cap growth funds, is in a slump. Over the past 12 months, Mid Cap lagged 87% of its peers, as well as its benchmark, the Russell Mid Cap index.

Two clunkers are mostly to blame. Shares of Dentsply Sirona, a maker of dental supplies and equipment, and Patterson Cos., a distributor of dental and animal health products, sank 29% and 51%, respectively, over the past year. A slowdown in demand hurt Dentsply, and Patterson is facing competition from online sellers. Fund managers Matt Gershuny and Lori Keith reduced their stake in Dentsply, but they believe the firm’s new executives are making the right moves. They expect profits to recover soon. The fund managers sold their Patterson shares. “Our patience wore thin,” says Keith, “and we saw better opportunities.”

Advertisement - Article continues below

Gershuny and Keith have managed Mid Cap for nearly 10 years. They focus on growing companies with a product or service that’s in demand and shares that trade at reasonable prices. And they invest only in companies that meet environmental, social and corporate governance standards.

Two new stocks are in the portfolio: Cadence Design Systems and Synopsys. Both are in the electronic design automation industry, which helps engineers design semiconductor chips. “Chips have become more integral to consumer devices, but they are used in the medical, industrial and automotive industries, too,” says Keith.

A mere 35 stocks fill the portfolio, a concentration that contributed to its recent woes. “If you own a limited number of stocks and a couple go sour, it has an impact on the portfolio,” says Gershuny.

On the plus side, Mid Cap has held up well in tough markets. Between January 26 and February 9, for instance, the Russell index fell 8.6%, but the fund lost only 6.2%. Mid Cap beat the index during longer rough patches, too, including the 2011 and 2014 calendar years.

Symbol change: Fidelity Strategic Income has a new symbol, FADMX, after merging with another fund.

Advertisement
Advertisement

Most Popular

11 Dividend-Paying Stocks You Should Think Twice About
dividend stocks

11 Dividend-Paying Stocks You Should Think Twice About

Dividend-paying stocks often can be a store of safety, but 2020 has been difficult on income equities. These 11 picks look like shaky plays despite th…
September 21, 2020
How To Buy a Roth IRA When You Make Too Much To Qualify For One
Roth IRAs

How To Buy a Roth IRA When You Make Too Much To Qualify For One

With their tax-free growth and tax-free withdrawals, Roth IRAs are a great deal — if you qualify. If you don’t, well, there’s still a way to get into …
September 23, 2020
Medicare Basics: 11 Things You Need to Know
Medicare

Medicare Basics: 11 Things You Need to Know

There's Medicare Part A, Part B, Part D, medigap plans, Medicare Advantage plans and so on. We sort out the confusion about signing up for Medicare --…
September 16, 2020

Recommended

10 of the Best Target-Date Fund Families
mutual funds

10 of the Best Target-Date Fund Families

The best target-date funds are a 'set it and forget it' approach to your retirement, but which fund family should you trust your money?
September 17, 2020
Best Bond Funds for Every Need
Investing for Income

Best Bond Funds for Every Need

In a changing market, it’s important to remember why we hold bonds in the first place.
September 15, 2020
How to Build a Bond Portfolio
Becoming an Investor

How to Build a Bond Portfolio

No single bond (or even bond fund) can do it all. We'll help you match your goals with appropriate fixed-income picks.
August 27, 2020
Time to Buy Japanese Shares?
Foreign Stocks & Emerging Markets

Time to Buy Japanese Shares?

In a weak global economy, T. Rowe Price Japan finds firms with healthy balance sheets.
August 27, 2020